Akoya Biosciences Inc (AKYA) — Financial Flexibility Index
Akoya Biosciences Inc (AKYA) has a Financial Flexibility Index of -0.06x as of March 2025. Free cash flow of $-7.01 Million (operating CF $-7.21 Million minus capex $204.00K) represents 0% of total liabilities ($118.54 Million). Check AKYA intangible-adjusted equity ratio to evaluate the tangible quality of the company's equity base.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Akoya Biosciences Inc Financial Flexibility Index (2019–2024)
Historical Financial Flexibility Index trend for Akoya Biosciences Inc across 6 annual periods. For the full cash flow conversion analysis, see Akoya Biosciences Inc (AKYA) cash conversion ratio.
Annual Financial Flexibility Index for Akoya Biosciences Inc (2019–2024)
Year-by-year free cash flow to debt coverage for Akoya Biosciences Inc. Explore Akoya Biosciences Inc (AKYA) cash flow to debt to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -0.35x | $-41.65 Million | $-44.10 Million | $117.41 Million | ▲ +5.0% |
| 2023 | -0.37x | $-47.25 Million | $-50.90 Million | $126.60 Million | ▲ +5.0% |
| 2022 | -0.39x | $-46.14 Million | $-53.50 Million | $117.45 Million | ▲ +11.8% |
| 2021 | -0.45x | $-30.97 Million | $-36.07 Million | $69.56 Million | ▼ -641.6% |
| 2020 | -0.06x | $-3.55 Million | $-6.84 Million | $59.09 Million | ▲ +34.2% |
| 2019 | -0.09x | $-10.91 Million | $-13.78 Million | $119.57 Million | — |